“While the termination of funding from HHS adds uncertainty, we are pleased by the robust immune response and safety profile ...

Bio-healthcare company Dx&Vx (DXVX) has officially announced the acceleration of its development program for a universal COVID-19 vaccine, following the recent acquisition of related technology.

Here’s what else you need to know to Get Up to Speed and On with Your Day. President Donald Trump’s economic agenda was thrown into chaos on Wednesday after a federal court ruled that he didn’t have ...

Moderna announced positive interim results from an early-stage trial of a vaccine that targeted bird flu virus.

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Who doesn't love spending more time in the summer sun? However, it's important to protect your skin and check for signs of ...

A new type of coronavirus vaccine administered nasally has proven effective when tested on animals, researchers at the ...

Department of Cancer Biology, The University of Kansas Medical Center, Cancer Center, Kansas City, Kansas 66160, United States Center of BioModular Multi-Scale Systems for Precision Medicine, The ...

Every year, the race begins anew. Scientists scramble to track mutating viruses, pharmaceutical companies reformulate ...

Shares of Vaccine stocks are moving higher on Tuesday after documents from the U.S. Food and Drug Administration revealed ...

On Friday evening, December 18, 2020 the United States Food & Drug Administration (FDA) approved Moderna’s mRNA Covid-19 vaccine for emergency use, joining Pfizer’s previously approved ...